China to Accept Foreign Trial Data to Speed Drug Approvals


download (2)

China said it plans to accept data from overseas clinical trials in an attempt to speed up drug approvals, a potential win for international drugmakers as well as local patients.

According to Reuters, in the past 15 years, China has approved just over 100 innovative new drugs — about one-third the number in developed markets. China’s pharmaceutical market is the second-largest in the world, according to BMI Research.

In addition to accepting overseas clinical data, the China Cabinet is also looking to improve the protection of medical intellectual property and boost the number and quality of clinical trial testing centers in China.

Continue at:–N0pCFOwXMo7B_nBz5ZHl5zAAiiPMQg&_hsmi=57196757

The text above is owned by the site bellow referred.

Here is only a small part of the article, for more please follow the link

Also see:

FDA Monthly News Roundup

1 Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s